Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Cephalon, Inc. (NASDAQ:CEPH.DL)

CAPS Rating: No stars

An international biopharmaceutical company dedicated to the discovery, development and marketing of innovative products to treat human diseases. Currently its four core therapeutic areas are central nervous system disorders, pain, cancer and addiction.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:CEPH.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

coryjobe (96.42)
Submitted July 23, 2010

Reported a 12% YOY increase in sales, managements focus on controlling spending helped improve the bottom line. High demand for NUVIGIL and PROVIGIL helped increase revenue from Central Nervous System by 14%. Thanks to t he leukemia drug TREANDA and… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:CEPH.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about CEPH.DL.

No one has written a Pitch for CEPH.DL stock yet. Tell us why you think CEPH.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in CEPH.DL.

No players have picked CEPH.DL yet. Tell us why you think CEPH.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for CEPH.DL.